Skip to content
Screener

Reported May 15, 2025 · Before market open

EPS-$0.32Miss by $0.02
EPS estimate-$0.30

Next report

Nov 12, 2026 (In 1 week)
EPS estimate-$0.18

FAQ

When did Actuate Therapeutics, Inc. report Q1 2025 earnings?
Actuate Therapeutics, Inc. (ACTU) reported Q1 2025 earnings on May 15, 2025 before market open.
What were Actuate Therapeutics, Inc.'s Q1 2025 revenue and EPS?
Actuate Therapeutics, Inc. reported eps of $-0.32 for Q1 2025.
Did Actuate Therapeutics, Inc. beat estimates in Q1 2025?
EPS missed the consensus estimate of $-0.30 by $0.02.
Where can I find Actuate Therapeutics, Inc.'s Q1 2025 SEC filings?
You can read the 10-Q periodic report (0001683168-25-003705) directly on SEC EDGAR. The filing index links above go to sec.gov.